MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Although allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for myelofibrosis (MF), data are limited on how molecular markers predict transplantation outcomes. We retrospectively evaluated transplantation outcomes of 110 consecutive MF patients who underwent allo...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Ali, Haris, Aldoss, Ibrahim, Yang, Dongyun, Mokhtari, Sally, Khaled, Samer, Aribi, Ahmed, Afkhami, Michelle, Al Malki, Monzr M., Cao, Thai, Mei, Matthew, O’Donnell, Margaret, Salhotra, Amandeep, Pullarkat, Vinod, Yang, Lixin, Stein, Anthony S., Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pillai, Raju, Snyder, David
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2019
主題:
Transplantation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325305/
https://ncbi.nlm.nih.gov/pubmed/30622146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018026658
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料